Urukingo rwa COVID-19 rwakozwe na Sinopharm yo mu Bushinwa kugirango ikoreshwe byihutirwa, byemejwe na OMS.

Urukingo rwa COVID-19 rwakozwe na Sinopharm yo mu Bushinwa

kubikoresha byihutirwa, byemejwe na OMS.

UwitekaIshami ry'Umuryango w'Abibumbye ryita ku Buzima (OMS)byemejwe ku ya karindwi Gicurasi urukingo rwa BBIBP-CorV COVID-19 rwakozwe na Sinopharm yo mu Bushinwa kugira ngo ikoreshwe byihutirwa.

Kuri iki gicamunsi, OMS yahaye urutonde rw’ibihe byihutirwa urukingo rwa COVID-19 rwa Sinopharm Beijing, rukaba ari urukingo rwa gatandatu rwakiriwe na OMS mu rwego rwo kubungabunga umutekano, gukora neza ndetse n’ubuziranenge », nk'uko byatangajwe n’umuyobozi mukuru wa OMS, Dr. Tedros Adhanom Ghebreyesus.

Ibi byagura urutonde rwinkingo COVAX ishobora kugura, kandi igaha ibihugu ikizere cyo kwihutisha ibyemezo byayo bwite, no gutumiza no gutanga urukingo.

 

Ni icyubahiro gikomeyeIkizamini cya endotoxin ya BioendoGira uruhare runini mukugenzura ubuziranenge bwa endotoxine mugutezimbere no gutanga urukingo rwa COVID-19 mubushinwa.

Turizera ko abantu kwisi yose bazishimira ibihe byamahoro nubuzima bwiza.

 

· Iyi ngingo yavuzwe mu Bushinwa Amakuru Yindimi ebyiri.